Reprogramming lipid metabolism in pediatric cancers

Area of Science:

• Oncology
• Metabolic Biochemistry
• Cancer Biology

Background:

• Metabolic reprogramming is crucial for cancer development and growth.
• Pediatric cancers utilize aberrant transcriptional networks to alter lipid metabolism.
• This rewiring involves activating biosynthetic pathways, membrane remodeling, and metabolic flexibility.

Purpose of the Study:

• To review recent advances in understanding lipid metabolism reprogramming in pediatric cancers.
• To examine key areas including transcriptional drivers, lipid catabolism, ferroptosis evasion, and tissue-specific adaptations.
• To discuss the clinical translation of targeting lipid metabolism in pediatric oncology.

Main Methods:

• Literature review synthesizing recent advances in pediatric cancer lipid metabolism.
• Analysis of transcriptional drivers of fatty acid and cholesterol synthesis.
• Examination of lipid catabolism roles in metabolic stress.
• Investigation of ferroptosis evasion mechanisms and metastatic adaptations.

Main Results:

• Transcriptional drivers activate fatty acid and cholesterol synthesis in pediatric cancers.
• Lipid catabolism supports energy, acetyl-CoA, and NADPH under stress.
• Cancer cells evade ferroptosis via desaturation and membrane remodeling.
• Metabolic adaptations facilitate metastasis to bone marrow and cerebrospinal fluid.

Conclusions:

• Preclinical studies identify vulnerabilities (e.g., FASN, SCD, HMGCR) but clinical impact is unproven.
• Challenges exist in translating lipid metabolism therapies to the clinic.
• Future success depends on understanding lipid flux and patient-specific dependencies.